Bailard Inc. Buys New Shares in Option Care Health, Inc. (NASDAQ:OPCH)

Bailard Inc. purchased a new position in Option Care Health, Inc. (NASDAQ:OPCH) during the 4th quarter, Holdings Channel reports. The firm purchased 15,220 shares of the company’s stock, valued at approximately $353,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Westfield Capital Management Co. LP grew its position in Option Care Health by 10.2% during the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after buying an additional 599,589 shares in the last quarter. Global Alpha Capital Management Ltd. lifted its position in shares of Option Care Health by 108.3% in the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock worth $1,559,000 after acquiring an additional 25,905 shares during the period. Graypoint LLC acquired a new stake in shares of Option Care Health during the 4th quarter worth approximately $1,161,000. Victory Capital Management Inc. increased its position in shares of Option Care Health by 4,432.8% during the third quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after purchasing an additional 1,585,818 shares during the period. Finally, Barclays PLC raised its stake in shares of Option Care Health by 180.1% in the third quarter. Barclays PLC now owns 310,194 shares of the company’s stock valued at $9,708,000 after purchasing an additional 199,454 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Stock Up 0.5 %

Shares of OPCH opened at $34.12 on Wednesday. The firm has a market capitalization of $5.81 billion, a price-to-earnings ratio of 28.67, a PEG ratio of 2.30 and a beta of 1.35. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $34.57. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The business’s fifty day moving average price is $29.15 and its two-hundred day moving average price is $28.09.

Analyst Ratings Changes

Several equities research analysts have issued reports on OPCH shares. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and boosted their price target for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Barrington Research upped their target price on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. UBS Group began coverage on shares of Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target for the company. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price objective (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Finally, JPMorgan Chase & Co. increased their target price on Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $32.88.

Insider Activity at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.64% of the stock is owned by company insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.